Ilyas Dr Juwairiya, Jamal Dr Mohd Arshad
Department of Amraze Jild wa Tazeeniyat (Dermatology and Cosmetology), National Institute of Unani Medicine, Bangalore, India.
Department of Amraze Jild wa Tazeeniyat (Dermatology and Cosmetology), National Institute of Unani Medicine, Bangalore, India.
Explore (NY). 2025 May-Jun;21(3):103138. doi: 10.1016/j.explore.2025.103138. Epub 2025 Mar 3.
Palmoplantar Keratoderma (PPK) is a heterogeneous group of hereditary and acquired cornification disorders defined by hyperkeratosis of the palms and soles, often resulting in significant discomfort and reduced quality of life. The clinical features include well defined yellowish hyperkeratotic plaques on palm and soles. Treatment typically relies on topical keratolytic agents, including salicylic acid, lactic acid, urea and in more severe cases, systemic therapy with oral retinoids may be required. While there are numerous case reports and published articles on the management of palmoplantar keratoderma within the framework of allopathic medicine, there is a noticeable scarcity of literature addressing the treatment of PPK through Unani medicine. Exploring Unani medicine for chronic skin conditions offers a promising alternative to conventional allopathic treatments, especially when the latter proves ineffective or causes undesirable side effects.
A 10-year-old male child presented with a two-year history of progressive thickening and hyperkeratosis of the palms and soles. The mother of the patient first noticed cracks on his left sole, which gradually progressed into thickened, rough lesions. After 6 months the same kind of lesion was observed on right sole gradually the lesions appear on right palm and then left palm. A diagnosis of palmoplantar keratoderma was made based on clinical findings and patient took the allopathic treatment on and off for several months but there was only minimal improvement and reappearance of lesions after few days, so the patient's family sought Unani medicine as an alternative therapy. After 6 weeks of Unani treatment, the patient showed remarkable improvement, including reduced skin thickening, relief from discomfort, and restored skin flexibility.
This case report highlights the successful resolution of PPK in a 10-year-old male child patient following treatment with Unani medicine. Moreover, it suggests the potential applicability of Unani medicine approach for managing chronic skin diseases. More controlled studies are required to determine its efficacy in other PPK cases. For chronic or complex skin diseases, using Unani medicine instead of traditional treatment may provide a more comprehensive approach and better outcomes.
掌跖角化病(PPK)是一组遗传性和获得性角质化疾病的统称,其特征为手掌和脚底的角质增生,常导致明显不适并降低生活质量。临床特征包括手掌和脚底出现边界清晰的淡黄色角质增生斑块。治疗通常依赖局部角质溶解剂,如水杨酸、乳酸、尿素,在更严重的情况下,可能需要口服维甲酸进行全身治疗。虽然在现代医学框架内有许多关于掌跖角化病治疗的病例报告和已发表文章,但关于通过尤纳尼医学治疗PPK的文献却明显匮乏。探索尤纳尼医学治疗慢性皮肤病为传统现代医学治疗提供了一个有前景的替代方案,尤其是当后者证明无效或引起不良副作用时。
一名10岁男童,有两年手掌和脚底进行性增厚和角质增生病史。患者母亲首先注意到他左脚脚底有裂缝,逐渐发展为增厚、粗糙的病变。6个月后,右脚脚底也出现了同样的病变,随后病变出现在右手掌,然后是左手掌。根据临床检查结果诊断为掌跖角化病,患者断断续续接受了几个月的现代医学治疗,但只有轻微改善,几天后病变又复发,因此患者家属寻求尤纳尼医学作为替代疗法。经过6周的尤纳尼医学治疗,患者有了显著改善,包括皮肤增厚减轻、不适感缓解以及皮肤柔韧性恢复。
本病例报告强调了一名10岁男童患者在接受尤纳尼医学治疗后成功治愈掌跖角化病。此外,这表明尤纳尼医学方法在管理慢性皮肤病方面具有潜在适用性。需要更多对照研究来确定其在其他PPK病例中的疗效。对于慢性或复杂的皮肤病,使用尤纳尼医学而非传统治疗可能提供更全面的方法和更好的结果。